Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Has results × marizomib × Clear all

Phase

Status

Sponsor Class

INDUSTRY 2 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Radiotherapy 81 Cisplatin 73 Cyclophosphamide 72 Vincristine 52 Doxorubicin 51 Paclitaxel 49 Carboplatin 46 Etoposide 44 Filgrastim 41 Prednisone 34 Methotrexate 34 Granulocyte Colony-Stimulating Factor 32 Platinum 29 Cytarabine 28 Gemcitabine 27 Docetaxel 27 Radiotherapy, Intensity-Modulated 26 Dexamethasone 26 Radiotherapy, Conformal 24 Leucovorin 24 Fluorouracil 24 Irinotecan 22 Cetuximab 22 Radiation 21 1,2-diaminocyclohexaneplatinum II citrate 21 Taxes 20 Rituximab 19 merphos 17 Temozolomide 17 Bevacizumab 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03345095 2025-07-01

MIRAGE

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed

749 enrolled 15 charts

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡